Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

Abstract Background Primary percutaneous coronary intervention is the treatment of choice in ST-segment elevation myocardial infarction and no-reflow phenomenon is still an unsolved problem. Methods We searched PubMed, EmBase, and Cochrane Central Register of Controlled Trials for relevant randomize...

Full description

Bibliographic Details
Main Authors: Ning Geng, Li Ren, Lisheng Xu, Deling Zou, Wenyue Pang
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Cardiovascular Disorders
Subjects:
Nicorandil
ST-segment elevation myocardial infarction
Primary percutaneous coronary intervention
No-reflow phenomenon
major adverse cardiovascular event
Online Access:https://doi.org/10.1186/s12872-021-02301-1

Internet

https://doi.org/10.1186/s12872-021-02301-1

Similar Items